Gene · 51206
Papers3,850
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,850
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Distinct Platelet Phenotype and Reactivity in Individuals with Permanent Atrial Fibrillation Treated with Direct Oral Anticoagulants: A Pilot Study. | Thromb Haemost | 2026 | 40499915 | PubTator, text mining | PubMed |
| Middle-Throughput LC-MS-Based Platelet Proteomics with Minute Sample Amounts Using Semiautomated Positive Pressure FASP in 384-Well Format. | Thromb Haemost | 2026 | 39814053 | PubTator, text mining | PubMed |
| Platelet Hyaluronan Synthase 3 Regulates Thrombin Signaling and Adhesion to Fibrinogen Under Venous Shear. | Proteoglycan Res | 2025 | 41586377 | PubTator, text mining | PubMed |
| Fibrin Monomer in Thrombosis and Haemostasis: A Clinical Biomarker and Beyond. | Int J Mol Sci | 2025 | 41465254 | PubTator, text mining | PubMed |
| Characterization of Novel Variants in P2YRY12, GP6 and TBXAS1 in Patients with Lifelong History of Bleeding. | Biomolecules | 2025 | 41463295 | PubTator, text mining | PubMed |
| Advancements in injection materials for submucosal lifting in endoscopic interventions. | World J Gastrointest Surg | 2025 | 41357655 | PubTator, text mining | PubMed |
| Genetic evidence for causal association between platelet count and glioma risk through Mendelian randomization analysis. | Discov Oncol | 2025 | 41264048 | PubTator, text mining | PubMed |
| Editorial: Significance cytokines in immuno oncology and immunotherapy. | Transl Oncol | 2025 | 41167916 | PubTator, text mining | PubMed |
A minimum valency of 4 is required for robust activation of platelets in flow cytometry by multivalent nanobodies to Glycoprotein VI, C-type lectin-like receptor 2 and Platelet Endothelial Aggregation Receptor 1. | Res Pract Thromb Haemost | 2025 | 41158673 | PubTator, text mining | PubMed |
| Immunoglobulin G N-glycosylation predicts long-term risk of ischemic stroke: a nested case-control study. | J Transl Med | 2025 | 41146300 | PubTator, text mining | PubMed |
| GPVI as a Potential New Biomarker for Myelofibrosis Diagnosis. | Am J Hematol | 2025 | 41024627 | PubTator, text mining | PubMed |
| Mechanisms of Thromboinflammation in Viral Infections-A Narrative Review. | Viruses | 2025 | 41012635 | PubTator, text mining | PubMed |
| Characteristics of Myelodysplastic Syndrome with Coagulation Abnormalities and Tailored Diagnosis and Treatment. | J Pers Med | 2025 | 41003132 | PubTator, text mining | PubMed |
| ApoC3 Attenuates Platelet Activation Through GPIIb/IIIa Receptor Interaction. | Cells | 2025 | 41002378 | PubTator, text mining | PubMed |
| Discovery of platelet glycoprotein VI receptor antagonists and their neuroprotective activity: an in silico, in vitro, and in vivo study. | 3 Biotech | 2025 | 40989769 | PubTator, text mining | PubMed |
| Reversible Platelet Aggregation Induced by Low-Temperature Storage in Heparinized Whole Blood Samples. | Hematol Rep | 2025 | 40981002 | PubTator, text mining | PubMed |
A Critical Review on BH3 Mimetic Drugs and the Treatment of Cancer-Associated Thrombosis (CAT): A Proposed Design for a Drug Delivery System Capable of Simultaneously Targeting Tumor Cells and Activated Platelets. | Cancer Med | 2025 | 40970582 | PubTator, text mining | PubMed |
| A Structural Bridge Between Kingdoms: How Collagen-Derived Peptides Influence Plant Stress and Growth Pathways. | Physiol Plant | 2025 | 40947508 | PubTator, text mining | PubMed |
| Blocking platelet glycoprotein VI (GPVI) as a promising antithrombotic treatment. | Drug Discov Today | 2025 | 40939697 | PubTator, text mining | PubMed |
| Preparation of cold-stored platelets on-demand: A novel approach to inventory management. | Transfusion | 2025 | 40910747 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51206/papers?page=5